Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;88(1):F6-10.
doi: 10.1136/fn.88.1.f6.

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

Affiliations

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

R Gottstein et al. Arch Dis Child Fetal Neonatal Ed. 2003 Jan.

Abstract

Objectives: To assess the effectiveness of high dose intravenous immunoglobulin (HDIVIG) in reducing the need for exchange transfusion in neonates with proven haemolytic disease due to Rh and/or ABO incompatibility. To assess the effectiveness of HDIVIG in reducing the duration of phototherapy and hospital stay.

Design: Systematic review of randomised and quasi-randomised controlled trials comparing HDIVIG and phototherapy with phototherapy alone in neonates with Rh and/or ABO incompatibility.

Results: Significantly fewer infants required exchange transfusion in the HDIVIG group (relative risk (RR) 0.28 (95% confidence interval (CI) 0.17 to 0.47); number needed to treat 2.7 (95% CI 2.0 to 3.8)). Also hospital stay and duration of phototherapy were significantly reduced.

Conclusion: HDIVIG is an effective treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of infants requiring exchange transfusions when comparing high dose intravenous immunoglobulin (HDIVIG) with phototherapy alone.
Figure 2
Figure 2
Number of infants requiring exchange transfusion when comparing high dose intravenous immunoglobulin with phototherapy alone (Rh disease only).
Figure 3
Figure 3
Number of infants requiring multiple exchange transfusions when comparing high dose intravenous immunoglobulin with phototherapy alone.
Figure 4
Figure 4
Mean length of hospital stay when comparing high dose intravenous immunoglobulin with phototherapy alone. WMD, Weighted mean difference.
Figure 5
Figure 5
Mean duration of phototherapy when comparing high dose intravenous immunoglobulin with phototherapy alone. WMD, Weighted mean difference.
Figure 6
Figure 6
Number of infants requiring red cell transfusions for late anaemia when comparing high dose intravenous immunoglobulin with phototherapy alone.

Comment in

References

    1. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F173-5 - PubMed
    1. Arch Dis Child Fetal Neonatal Ed. 2002 Mar;86(2):F135-6 - PubMed
    1. Acta Paediatr. 1999 Feb;88(2):216-9 - PubMed
    1. Arch Dis Child Fetal Neonatal Ed. 1998 Jan;78(1):F62-6 - PubMed
    1. Br J Haematol. 1979 Jun;42(2):315-25 - PubMed

Publication types

MeSH terms

Substances